Taro Pharmaceuticals Inc. Product Recall (2020-07-20)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
A. Dermovate Cream
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| AB28534 | Taro-Clobetasol Cream USP, 0.05% | - Recalling Firm
- Taro Pharmaceuticals Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Taro Pharmaceuticals Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| DIN 02245523 | Cream | Clobetasol Propionate, 0.05% |
| AB40179 | Dermovate Cream | - Recalling Firm
- Taro Pharmaceuticals Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
- Marketing Authorization Holder
- Taro Pharmaceuticals Inc.
- 126 East Drive
- Brampton
- L6T 1C1
- Ontario
- CANADA
| DIN 02213265 | Cream | Clobetasol Propionate, 0.05% |
-
Dermovate Cream
-
Taro-Clobetasol Cream USP, 0.05%
The content uniformity may be out of specification in the affected lots.